Jones Financial Companies
MRNA icon

Jones Financial Companies’s Moderna MRNA Stock Holding History

Jones Financial Companies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Buy
42,835
+3,084
+8% +$144K ﹤0.01% 1402
2025
Q4 		$1.17M Sell
39,751
-5,497
-12% -$149K ﹤0.01% 1166
2025
Q3 		$1.11M Buy
45,248
+306
+0.7% +$8.54K ﹤0.01% 1095
2025
Q2 		$1.22M Buy
44,942
+14,246
+46% +$375K ﹤0.01% 933
2025
Q1 		$955K Buy
30,696
+15,855
+107% +$563K ﹤0.01% 881
2024
Q4 		$617K Buy
14,841
+7,883
+113% +$377K ﹤0.01% 912
2024
Q3 		$457K Buy
6,958
+2,666
+62% +$245K ﹤0.01% 852
2024
Q2 		$510K Buy
4,292
+3,352
+357% +$424K ﹤0.01% 564
2024
Q1 		$100K Buy
+940
New +$94.8K ﹤0.01% 590
2023
Q2 		– Sell
-150
Closed -$23K – 570
2023
Q1 		$23K Buy
150
+112
+295% +$18.5K ﹤0.01% 410
2022
Q4 		$7K Buy
+38
New +$6.21K ﹤0.01% 511

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return